Resistance to anti-angiogenic therapy in pediatric solid tumors.
|
Feinstein Institute for Medical Research - North Shore / Samuel Soffer, MD |
Young Investigator Grants |
2007 |
New York |
Elucidating Mechanisms Driving Renal Medullary Carcinomas to Deliver a Rational Approach to Cancer
Directed Therapy
|
Dana-Farber Cancer Institute / Andrew Hong, MD |
Young Investigator Grants |
2015 |
Massachusetts |
Divergent Core Transcriptional Regulatory Circuitries to Highlight Context-Specific Vulnerabilities in AML |
Dana-Farber Cancer Institute / Maxim Pimkin, MD/PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Modeling H3 G34R and BCOR-Altered Glioma Pathogenesis Using Neural Stem Cells |
The Johns Hopkins University School of Medicine / Satoshi Nakata, MD/PhD |
Young Investigator Grants |
2019 |
Maryland |
The Role of DNA Methylation in Pediatric Cancer |
Fred Hutchinson Cancer Research Center / Scott Diede |
Young Investigator Grants |
2010 |
Washington |
The Identification of Neuroblastoma Cancer Stem Cells.
|
Stanford University / Robert Cho |
Young Investigator Grants |
2007 |
California |
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Identification of Alveolar Rhabdomyosarcoma "Achilles' Heel" |
National Cancer Institute / Fernanda Arnaldez |
Young Investigator Grants |
2011 |
Maryland |
Identification of Mechanisms of Resistance to Trametinib Monotherapy in PAX-fusion Negative Rhabdomyosarcoma |
National Cancer Institute / Marielle Yohe, MD/PhD |
Young Investigator Grants |
2016 |
Maryland |
An Exploration of the Medulloblastoma and Glioblastoma Genomes: A Critical Analysis of Candidate Cancer Genes as Potential Molecular Targets for Diagnostics and Therapeutics
|
The Johns Hopkins University School of Medicine / Will Parsons, MD, PhD |
Young Investigator Grants |
2007 |
Maryland |